ARSHAD KHANANI: Open Payments
NPI 1295929511 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424,127 in 228 payments from 20 companies in 2025. Trend: 2023 $285,498 · 2024 $312,929 · 2025 $424,127
Consulting: $376,281Speaker / faculty: $24,400Travel & lodging: $15,032Food & beverage: $4,314Honoraria: $4,100
| Company | Payments | Amount |
|---|---|---|
| Ocular Therapeutix, Inc. | 90 | $115,232 |
| Astellas Pharma US Inc | 36 | $107,663 |
| F. Hoffmann-La Roche AG | 18 | $51,025 |
| Astellas Pharma Global Development | 10 | $46,013 |
| Genentech, Inc. | 6 | $29,836 |
| ABBVIE INC. | 20 | $28,927 |
| SANOFI US SERVICES INC. | 2 | $15,903 |
| Apellis Pharmaceuticals, Inc. | 2 | $5,430 |
| Amgen Inc. | 1 | $5,250 |
| Genentech USA, Inc. | 23 | $4,754 |
Products named: Izervay, Vabysmo, OZURDEX, Lucentis, Syfovre, PAVBLU, PURIFIED CORTROPHIN GEL, Cequa.
Industry payments across NV — which companies pay providers there.
